Release Date: February 20, 2020
Expiration Date: February 19, 2021
Recently, advances in the understanding of the pathogenesis of multiple sclerosis, particularly the crosstalk between B and T cells, has led to a change in therapeutic approach, with an emphasis on the use of highly active approaches earlier in the disease process. Clinicians, armed with an understanding of the differential effects of highly active regimens, including immune-reconstitution therapies (IRTs) vs maintenance therapies, can make more educated risk:benefit assessments to inform optimal strategies for initial and sequential therapy for patients with relapsing/remitting MS. As new therapies become available, this conceptual schema must expand and incorporate the newer options. While knowledge and facility in this new approach is important for neurologists, other members of the care team, including advanced practice providers, neurology nurses, pharmacists, and patients must be informed and educated in order to address the realities of shared decision making, monitoring for and management of adverse effects, drug-drug interactions, and adherence to therapy.
To address these challenges, this initiative The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles in MS, will review the immunology of MS and its application in therapeutic selection. Using case examples, the faculty will address the disease, drug, and patient factors affecting the choice of initial and sequential therapies. Triple accredited for physicians, nurses, and pharmacists, this activity will appeal to the entire range of clinicians who care for MS patients. Downloadable patient education materials related to this new approach are also included.
Bruce A. Cohen, MD
Chief of MS/Neuroimmunology
Ken and Ruth Davee Department of Neurology
Professor of Neurology (MS/Neuroimmunology)
Northwestern University Feinberg School of Medicine
Jacquelyn (Jacci) Bainbridge, BS Pharm, PharmD, FCCP, MSCS
Professor, Department of Clinical Pharmacy
University of Colorado
Anschutz Medical Campus
Skaggs School of Pharmacy, Department of Clinical Pharmacy and Neurology
Amy Perrin Ross, RN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Medical Center
ACCREDITATION AND CREDIT DESIGNATION
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and the Terranova Medica LLC. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Consortium of Multiple Sclerosis Centers designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Consortium of Multiple Sclerosis Centers designates this activity for 2.0 contact hours of continuing education (2.0 in the area of pharmacology) for nurses.
The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education and will award 0.2 contact hours (0.2 CEUs) to pharmacists who (1) complete the activity, (2) submit a passing posttest, and (3) complete the evaluation form. The Universal Activity Number (UAN) for this activity is JA4008165-9999-20-003-H01-P. This is a knowledge-based activity.
Upon successful completion of the activity, your CE credits will be submitted electronically to the NABP CPE Monitor service. For information about CPE Monitor, visit https://nabp.pharmacy/cpe-monitor-service/
Certificate of Attendance for Other Healthcare Professionals
A Certificate of Attendance will be given upon completion of course requirements enabling participants to register their credit with the appropriate licensing boards or associations. Participants may apply for other accreditations using procedures established by specific organizations.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant received from EMD Serono.